Galectin's belapectin shows promise in MASH cirrhosis despite setbacks. High-risk investment with upcoming FDA meeting ...

If you are looking for an AI stock that is more promising than MERCK & CO., INC. (NYSE:MRK) and that has 10,000% upside potential, check out our report about this cheapest AI stock.

Merck MRK stock has declined 4% since it announced second-quarter results on July 29 before market open. While the company’s earnings beat estimates, its sales came in line.

Another of his key initiatives is to firmly oppose a “Reverse Stock Split”, reflecting the Company’s “Stockholders First” philosophy. FF has been added to the Russell 3000 Index.

Detailed price information for Mersana Therapeutics Inc (MRSN-Q) from The Globe and Mail including charting and trades.

Merck is a strong and profitable pick meeting Benjamin Graham's criteria. Read more on why investors need to stay aware of potential downside risks before investing.

A change in full-year guidance by management wasn't particularly welcome.

Merck's Phase 3 trial shows Keytruda plus Padcev improves survival in muscle-invasive bladder cancer patients ineligible for cisplatin therapy.

These are the upcoming stock splits for the week of August 18 to August 22, based on TipRanks’ Stock Splits Calendar. A stock ...